Catherine Delsecco, PA
Medical · Mercer Island, WANPI 1720150105
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.5% of the total across 391 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by Novartis at 25.4% of the total. Among medical clinicians in WA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 391 payments — averaging $15.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$2K
- AbbVie$1K
- Johnson & Johnson$515
- E.r. Squibb & Sons, L.L.C.$400
- Lilly USA, LLC$274
- Galderma Laboratories, L.p.$268
- plus $2K from 13 others
What the payments were for
- Food & beverage$6,09598%
- Education$932%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 146 | $1,573 |
| AbbVie | 70 | $1,410 |
| Johnson & Johnson | 34 | $515 |
| E.r. Squibb & Sons, L.L.C. | 29 | $400 |
| Lilly USA, LLC | 13 | $274 |
| Galderma Laboratories, L.p. | 12 | $268 |
| Incyte Corporation | 9 | $236 |
| Regeneron Healthcare Solutions, Inc. | 10 | $227 |
| Arcutis Biotherapeutics, Inc. | 17 | $224 |
| Sanofi | 8 | $211 |
| UCB, Inc. | 9 | $186 |
| Dermavant Sciences, Inc. | 9 | $181 |
| Pfizer | 6 | $122 |
| Amgen | 6 | $99 |
| Organogenesis Inc. | 5 | $99 |
| Sun Pharmaceutical Industries Inc. | 4 | $74 |
| Organon | 2 | $41 |
| Pharming Healthcare, Inc. | 1 | $30 |
| LEO Pharma Inc. | 1 | $16 |
How this compares
$6,188 in reported general payments places this provider in the 90th percentile of 457 medical providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 51 | $1,846 |
| Clobetasol Propionate | 23 | $1,061 |
| Ketoconazole | 23 | $582 |
| Doxycycline Hyclate | 37 | $514 |
| Mupirocin | 29 | $295 |
| Minoxidil | 22 | $56 |
| Clotrimazole | 19 | $43 |
Paid to pharmacies, not to this prescriber.
Other medical in Mercer Island
- Diana McFarlaneSeattle$95K
- Karissa SecoraTacoma$53K
- Tori FranklinLakewood$23K
- Salvador LopezYakima$17K
- Amy NelsonSeattle$15K
- Rebecca JohnsonSpokane$14K
- Jonathan CyphersBurien$13K
- Jonathan WhiteSeattle$13K
- Julia TaylorSpokane$12K
- Kristine WesselsSpokane$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.